SURVEILLANCE SUPPORT FOR EMERGING DISEASES AND CLINICAL TRIALS IN CAMBODIA.
Award details are derived from public USAspending.gov records. Not a bid recommendation.
Award details
- Award ID
- HT942523P0103
- Contractor
- CHENDA POLYCLINIC COMPANY LIMITED
- Awarding agency
- Department of Defense
- Sub-agency / office
- Defense Health Agency
- Award amount
- $1,482,736
- Period of performance
- Sep 15, 2023 – Sep 18, 2026
- NAICS
- 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- PSC AN11
- Place of performance
- KHM
- Competition
- COMPETED UNDER SAP · Set-aside: NO SET ASIDE USED. · 3 offers
- Pricing
- FIRM FIXED PRICE
- Financial breakdown
- Current value $1,482,736 · Obligated $1,482,736 · Potential value $2,361,447 · Latest action obligation $50,000 · Outlays $207,150
Public award description
SURVEILLANCE SUPPORT FOR EMERGING DISEASES AND CLINICAL TRIALS IN CAMBODIA.
Find out who's winning similar federal contracts
Discover comparable awards, related contractors, and agency purchasing history.